These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33421579)

  • 1. The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients.
    Dadon Z; Ben-Chetrit E; Benjaminov O; Taha L; Wiener-Well Y; Belman D; Levin PD
    Clin Microbiol Infect; 2021 Apr; 27(4):635.e1-635.e4. PubMed ID: 33421579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.
    Meschiari M; Kaleci S; Orlando G; Selmi S; Santoro A; Bacca E; Menozzi M; Franceschini E; Puzzolante C; Bedini A; Sarti M; Venturelli C; Vecchi E; Mussini C
    Antimicrob Resist Infect Control; 2021 Apr; 10(1):69. PubMed ID: 33832538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental colonization and onward clonal transmission of carbapenem-resistant
    Ng DHL; Marimuthu K; Lee JJ; Khong WX; Ng OT; Zhang W; Poh BF; Rao P; Raj MDR; Ang B; De PP
    Antimicrob Resist Infect Control; 2018; 7():51. PubMed ID: 29644052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
    Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
    Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 9. Adaptations of carbapenem resistant
    Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid screening and early precautions for carbapenem-resistant
    Yamamoto N; Hamaguchi S; Akeda Y; Santanirand P; Chaihongsa N; Sirichot S; Chiaranaicharoen S; Hagiya H; Yamamoto K; Kerdsin A; Okada K; Yoshida H; Hamada S; Oishi K; Malathum K; Tomono K
    Antimicrob Resist Infect Control; 2019; 8():110. PubMed ID: 31297191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
    Henig O; Weber G; Hoshen MB; Paul M; German L; Neuberger A; Gluzman I; Berlin A; Shapira C; Balicer RD
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2063-8. PubMed ID: 26205665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.
    Chung YK; Kim JS; Lee SS; Lee JA; Kim HS; Shin KS; Park EY; Kang BS; Lee HJ; Kang HJ
    Am J Infect Control; 2015 Nov; 43(11):1171-7. PubMed ID: 26297525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired in name only: A cluster of carbapenem-resistant
    Shenoy ES; Pierce VM; Sater MRA; Pangestu FK; Herriott IC; Anahtar MN; Bramante JT; Kwon DS; Hawkins FR; Suslak D; West LR; Huntley MH; Hooper DC
    Infect Control Hosp Epidemiol; 2020 May; 41(5):531-538. PubMed ID: 32106898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental exposure to carbapenem-resistant Acinetobacter baumannii as a risk factor for patient acquisition of A. baumannii.
    Rosa R; Arheart KL; Depascale D; Cleary T; Kett DH; Namias N; Pizano L; Fajardo-Aquino Y; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):430-3. PubMed ID: 24602951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
    Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.